TGFB1 and diabetic kidney disease: It induces macrophage chemotaxis, modulates the NO signaling pathway, and mediates the release of inflammatory and fibrotic factors (such as Ang II, TGF-β, endothelin-1) implicated in the pathogenesis of DKD, contributing to tubulointerstitial damage (201, 202).